Drug Shortage Report for ALPROLIX
Report ID | 166863 |
Drug Identification Number | 02422948 |
Brand name | ALPROLIX |
Common or Proper name | ALPROLIX 2000 |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN |
Strength(s) | 2000UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 VIAL & 5 ML PREFILLED DILUENT SYRINGE |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-08-17 |
Actual start date | 2022-08-17 |
Estimated end date | 2022-09-09 |
Actual end date | 2022-08-26 |
Shortage status | Resolved |
Updated date | 2022-08-28 |
Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-28 | French | Compare |
v6 | 2022-08-28 | English | Compare |
v5 | 2022-08-26 | French | Compare |
v4 | 2022-08-26 | English | Compare |
v3 | 2022-08-18 | English | Compare |
v2 | 2022-08-16 | French | Compare |
v1 | 2022-08-16 | English | Compare |
Showing 1 to 7 of 7